TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32888011

Group type: EXPERIMENTAL
Intervention: Site calculation of anatomical SYNTAX score (SS) based on coronary computed tomography angiography (CTA)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Core laboratory (CL) calculation of anatomical SYNTAX score (SS) based on coronary computed tomography angiography (CTA)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Site calculation of functional SYNTAX score (SS) based on coronary CTA and fractional flow reserve derived from computed tomography (FFRCT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Core laboratory (CL) calculation of functional SYNTAX score (SS) based on coronary CTA and FFRCT
Number of subjects: 223

Group type: COMPARATOR
Intervention: Comparison of treatment recommendation based on anatomical SYNTAX score (SS) between sites and CL
Number of subjects: 223

Group type: COMPARATOR
Intervention: Comparison of treatment recommendation based on functional SYNTAX score (SS) between sites and CL
Number of subjects: 223
Study: 32180573

Group type: EXPERIMENTAL
Intervention: Cogswell triangular flap modified and transposed
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cogswell triangular flap
Number of subjects: 0
Study: 36177759

Group type: EXPERIMENTAL
Intervention: Physical therapist-led care (personalized hip therapy)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Arthroscopy
Number of subjects: 43
Study: 32776431

Group type: EXPERIMENTAL
Intervention: HIV self‐testing (HIVST) intervention
Number of subjects: 10111

Group type: EXPERIMENTAL
Intervention: Current PrEP users
Number of subjects: 10111

Group type: EXPERIMENTAL
Intervention: Men reporting at least two recent condomless anal intercourse (CAI) partners
Number of subjects: 10111
Study: 36321647

Group type: EXPERIMENTAL
Intervention: Calcipotriol-Betamethasone Dipropionate (Cal/BD) foam
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Calcipotriol-Betamethasone Dipropionate (Cal/BD) foam with AFL
Number of subjects: 11

Group type: COMPARATOR
Intervention: Calcipotriol-Betamethasone Dipropionate (Cal/BD) foam alone
Number of subjects: 11
Study: 34272041

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus nab-paclitaxel (A + nP)
Number of subjects: 902

Group type: COMPARATOR
Intervention: Placebo plus nab-paclitaxel (P + nP)
Number of subjects: 902
Study: 32465861

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) 81 mg daily
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 34982718

Group type: EXPERIMENTAL
Intervention: Mole's Veggie Adventures app used at least once a week for 3-4 weeks
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control group (no app intervention)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Mole's Veggie Adventures app
Number of subjects: 221
Study: 33321452

Group type: EXPERIMENTAL
Intervention: NTCELL® administration (putaminal encapsulated porcine choroid plexus cells)
Number of subjects: 18
Study: 35018643

Group type: EXPERIMENTAL
Intervention: Esketamine (0.2 mg/kg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 80
Study: 34062957

Group type: EXPERIMENTAL
Intervention: Angiotensin II (Ang II)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32615613

Group type: EXPERIMENTAL
Intervention: 2×20 g carbohydrates (muesli bars)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Preventive carbohydrate administration
Number of subjects: 24

Group type: COMPARATOR
Intervention: No preventive carbohydrates
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2×10 g carbohydrates (muesli bars)
Number of subjects: 24
Study: 37749861

Group type: EXPERIMENTAL
Intervention: i-PRF + SRP
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline + SRP
Number of subjects: 26
Study: 33249552

Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (ESK) plus oral antidepressant (OAD)
Number of subjects: 565

Group type: COMPARATOR
Intervention: Oral antidepressant (OAD) plus placebo nasal spray (PBO)
Number of subjects: 565
Study: 32283048

Group type: EXPERIMENTAL
Intervention: Virtual Therapy (VT) for 8 weeks, approximately 45 minutes twice weekly on the Jintronix Rehabilitation System
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 60
Study: 36254909

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided (USG) technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Palpation technique
Number of subjects: 80
Study: 33581476

Group type: EXPERIMENTAL
Intervention: Augmented reality (AR) books
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard children's book
Number of subjects: 29
Study: 32771017

Group type: COMPARATOR
Intervention: Standard approach to scaling-up SNaP
Number of subjects: 6200

Group type: EXPERIMENTAL
Intervention: Tailored approach to scaling-up SNaP
Number of subjects: 6200
Study: 32920135

Group type: EXPERIMENTAL
Intervention: Andiroba oil (Carapa guianensis Aubl)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low power laser
Number of subjects: 60
Study: 33218741

Group type: EXPERIMENTAL
Intervention: Rapid Deployment Valves (RDVs)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Traditional biological valves
Number of subjects: 239
Study: 34716201

Group type: EXPERIMENTAL
Intervention: SCO-267, a GPR40 Full Agonist
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33258102

Group type: EXPERIMENTAL
Intervention: Cangrelor and ticagrelor
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard therapy (ticagrelor alone)
Number of subjects: 22
Study: 34597783

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study: 33356905

Group type: EXPERIMENTAL
Intervention: 10Hz transcranial alternating current stimulation (10Hz-tACS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active sham stimulation
Number of subjects: 0
Study: 33971155

Group type: EXPERIMENTAL
Intervention: Voclosporin (23.7 mg twice daily)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Voclosporin
Number of subjects: 357
Study: 35123525

Group type: EXPERIMENTAL
Intervention: Inverted syringe technique
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 54
Study: 32891074

Group type: EXPERIMENTAL
Intervention: Problem-Based Learning (PBL)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Traditional instruction (Control)
Number of subjects: 2
Study: 36200397

Group type: EXPERIMENTAL
Intervention: Coach2Move
Number of subjects: 292

Group type: COMPARATOR
Intervention: UCP
Number of subjects: 292
Study: 33022048

Group type: EXPERIMENTAL
Intervention: Brief behavioral treatment for insomnia (BBTI)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Progressive muscle relaxation training (PMRT)
Number of subjects: 91
Study: 32992927

Group type: EXPERIMENTAL
Intervention: Outdoor multisurface terrain training
Number of subjects: 22
Study: 34915273

Group type: EXPERIMENTAL
Intervention: Total carbohydrate (30-g increment)
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Glycemic load (20-unit increment)
Number of subjects: 1279
Study: 34155908

Group type: EXPERIMENTAL
Intervention: Wavelet-based method for estimating time-varying functional connectivity (TVFC)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Wavelet-based method for estimating TVFC
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: MVPR method
Number of subjects: 400
Study: 32928298

Group type: EXPERIMENTAL
Intervention: MA&R in addition to standard mental healthcare
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard mental healthcare alone
Number of subjects: 128
Study: 36008827

Group type: EXPERIMENTAL
Intervention: Accelerated KRT initiation
Number of subjects: 2927
Study: 33972265

Group type: EXPERIMENTAL
Intervention: Predictive Intelligent Control of Oxygenation (PRICO)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Routine Manual Control (RMC)
Number of subjects: 27
Study: 32815759

Group type: EXPERIMENTAL
Intervention: 20 µg hepatitis B vaccine (IM20 group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 60 µg hepatitis B vaccine (IM60 group)
Number of subjects: 50
Study: 35461248

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (VR)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no VR)
Number of subjects: 42
Study: 32297449

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Background-medication-based individualized comparators (BMICs) including enalapril, valsartan, or placebo
Number of subjects: 0
Study: 33592641

Group type: EXPERIMENTAL
Intervention: Plyometric training with agility ladder (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 20
Study: 32750571

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 8240

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 8240

Group type: COMPARATOR
Intervention: Heparin lead-in
Number of subjects: 8240

Group type: EXPERIMENTAL
Intervention: Overall anticoagulation treatment
Number of subjects: 8240
Study: 35590185

Group type: EXPERIMENTAL
Intervention: Environmental alcohol prime
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Safe sex message prime
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Either or both prime(s)
Number of subjects: 80
Study: 33511549

Group type: EXPERIMENTAL
Intervention: Non-operative treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Operative treatment
Number of subjects: 0
Study: 33097380

Group type: EXPERIMENTAL
Intervention: Random nucleus location within the cell; calculated S-values using Geant4-DNA for mono energetic electrons (10–100 keV) with varying nucleus positions.
Number of subjects: 0
Study: 34808130

Group type: EXPERIMENTAL
Intervention: Fetoscopic endoluminal tracheal occlusion
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Fetoscopic endoluminal tracheal occlusion with early balloon insertion
Number of subjects: 287

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 287
Study: 33940665

Group type: EXPERIMENTAL
Intervention: Stannous-containing fluoride dentifrice
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium fluoride dentifrice (negative control)
Number of subjects: 100
Study: 34252302

Group type: EXPERIMENTAL
Intervention: Dose-ranging rifapentine
Number of subjects: 662
Study: 32198409

Group type: EXPERIMENTAL
Intervention: G-CSF group (82 patients)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (75 patients)
Number of subjects: 157
Study: 35390539

Group type: EXPERIMENTAL
Intervention: Small bowel capsule endoscopy (SBCE) in patients with surgically altered gastric anatomy
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (native gastric anatomy)
Number of subjects: 207
Study: 33884731

Group type: EXPERIMENTAL
Intervention: Barrier cream
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Antioxidant
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Barrier cream/micellar water
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Antioxidant/micellar water
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 64
Study: 34086294

Group type: EXPERIMENTAL
Intervention: War metaphor article
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Change metaphor article
Number of subjects: 1128

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 1128
Study: 32440101

Group type: COMPARATOR
Intervention: Dupilumab 300mg subcutaneously administered, added to standard intranasal steroid mometasone furoate, duration of treatment: 24 weeks (SINUS-24) or 52 weeks (SINUS-52) with varying injection frequency.
Number of subjects: 0
Study: 35450525

Group type: EXPERIMENTAL
Intervention: Medium-term low-dose melatonin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Exogenous melatonin supplements
Number of subjects: 50
Study: 33340185

Group type: EXPERIMENTAL
Intervention: One-handed airway
Number of subjects: 60

Group type: COMPARATOR
Intervention: Two-handed airway
Number of subjects: 60
Study: 35798596

Group type: EXPERIMENTAL
Intervention: i-PRF group (intraarticular injection of injectable platelet-rich fibrin after arthrocentesis)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (arthrocentesis procedure alone)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 33910617

Group type: EXPERIMENTAL
Intervention: Nelfinavir 750 mg orally, three times daily for 14 days
Number of subjects: 120

Group type: COMPARATOR
Intervention: Symptomatic treatment (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 120
Study: 33865401

Group type: EXPERIMENTAL
Intervention: 3D printed tooth-borne tissue retraction devices (TRDs)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional dental splints
Number of subjects: 34
Study: 32169307

Group type: EXPERIMENTAL
Intervention: Participants with SSD (49 out of 140, 35%)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Participants without SSD
Number of subjects: 140
Study: 35266669

Group type: EXPERIMENTAL
Intervention: Implant + connective tissue graft
Number of subjects: 42

Group type: COMPARATOR
Intervention: Implant
Number of subjects: 42
Study: 33811868

Group type: EXPERIMENTAL
Intervention: Survival pictograph first
Number of subjects: 839

Group type: EXPERIMENTAL
Intervention: Disability pictograph first
Number of subjects: 839

Group type: COMPARATOR
Intervention: Level of description of NICU experiences
Number of subjects: 839
Study: 32163106

Group type: COMPARATOR
Intervention: Weekly paclitaxel and nonpegylated liposomal doxorubicin (PM) with additional carboplatin (PMCb) for TNBC patients
Number of subjects: 914

Group type: COMPARATOR
Intervention: Sequential intense dose‐dense epirubicin, paclitaxel, and cyclophosphamide (iddEPC)
Number of subjects: 914

Group type: COMPARATOR
Intervention: Not applicable (non-BRCA1/2 BC predisposition genes)
Number of subjects: 914

Group type: COMPARATOR
Intervention: Not applicable (ERBB2-negative, hormone receptor-positive BC)
Number of subjects: 914
Study: 35289926

Group type: EXPERIMENTAL
Intervention: Supervised moderate-intensity aerobic and resistance training for 20 weeks followed by 32 weeks of unsupervised exercise (IMPROVE)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Support group plus Fitbit (SG+Fitbit) program for 20 weeks followed by 32 weeks of unsupervised activity
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Supervised moderate-intensity aerobic and resistance training
Number of subjects: 213
Study: 35638392

Group type: EXPERIMENTAL
Intervention: Positive airway pressure (PAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33965683

Group type: EXPERIMENTAL
Intervention: Telemedical treatment
Number of subjects: 225

Group type: COMPARATOR
Intervention: On-site treatment
Number of subjects: 225
Study: 32842955

Group type: EXPERIMENTAL
Intervention: Midazolam administered by a cardiologist
Number of subjects: 69

Group type: COMPARATOR
Intervention: Propofol with anaesthesiologist assistance
Number of subjects: 69
Study: 35616368

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 66
Study: 33473017

Group type: EXPERIMENTAL
Intervention: Chloroquine nasal drops (0.03%) administered six times daily (0.5 ml/dose) for 10 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard supportive treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chloroquine nasal drops (0.03%)
Number of subjects: 60
Study: 32703307

Group type: EXPERIMENTAL
Intervention: Dignity therapy (DT)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 144
Study: 34775250

Group type: EXPERIMENTAL
Intervention: Mindfulness retreat
Number of subjects: 95

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 95
Study: 34347255

Group type: EXPERIMENTAL
Intervention: Umeclidinium/Vilanterol
Number of subjects: 2444
Study: 32448401

Group type: EXPERIMENTAL
Intervention: 15 mg/day of prednisolone (PSL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 30 mg/day of prednisolone (PSL)
Number of subjects: 90
Study: 35491532

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg daily
Number of subjects: 98

Group type: COMPARATOR
Intervention: Guideline-recommended treatment (except for SGLT2 inhibitors)
Number of subjects: 98
Study: 32950737

Group type: EXPERIMENTAL
Intervention: Active case finding (ACF)
Number of subjects: 12566

Group type: COMPARATOR
Intervention: Passive case finding (PCF)
Number of subjects: 12566
Study: 35025687

Group type: EXPERIMENTAL
Intervention: Compression plus chemotherapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Chemotherapy (control)
Number of subjects: 25
Study: 34749770

Group type: EXPERIMENTAL
Intervention: Topical low-dose calcipotriol ointment (0.05 µg/g)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 32831097

Group type: EXPERIMENTAL
Intervention: Robot-assisted neurocognitive hand therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional neurocognitive therapy
Number of subjects: 33
Study: 34470841

Group type: EXPERIMENTAL
Intervention: Pulmonary tuberculosis patients who experienced unplanned readmission within 31 days after discharge.
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Age >65 years
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Rural residence
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Active smoking
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Chronic obstructive pulmonary disease (COPD)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Leaving hospital against medical advice
Number of subjects: 402
Study: 35170837

Group type: EXPERIMENTAL
Intervention: Optimised minus lens (OML) therapy, power ranged between -1.00D and -6.25D
Number of subjects: 141

Group type: COMPARATOR
Intervention: Observation group (corrected for any significant refractive error)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Optimised minus lens (OML) therapy
Number of subjects: 141
Study: 33705240

Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart repair
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 40
Study: 32491278

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mind-body exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise (general)
Number of subjects: 0
Study: 35357762

Group type: EXPERIMENTAL
Intervention: HIAE - high‐intensity aerobic exercise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: AE+BFR - aerobic exercise with blood flow restriction
Number of subjects: 22

Group type: COMPARATOR
Intervention: AE - aerobic exercise without BFR
Number of subjects: 22

Group type: COMPARATOR
Intervention: CON - non-exercise control condition
Number of subjects: 22
Study: 34587971

Group type: EXPERIMENTAL
Intervention: DMPA‐IM
Number of subjects: 552

Group type: COMPARATOR
Intervention: Copper IUD
Number of subjects: 552

Group type: COMPARATOR
Intervention: LNG implant
Number of subjects: 552

Group type: COMPARATOR
Intervention: DMPA‐IM vs IUD
Number of subjects: 552

Group type: COMPARATOR
Intervention: LNG implant vs IUD
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 552
Study: 32795983

Group type: EXPERIMENTAL
Intervention: Reminder+COM‐B Message intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Reminder‐only Message active control
Number of subjects: 34
Study: 36454914

Group type: EXPERIMENTAL
Intervention: Circle of Security‐Parenting intervention (COS‐P)
Number of subjects: 78
Study: 34544469

Group type: EXPERIMENTAL
Intervention: Peer-led chronic pain management program (PAP)
Number of subjects: 0
Study: 32101872

Group type: EXPERIMENTAL
Intervention: Hipcref diet intervention
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 128
Study: 35618247

Group type: EXPERIMENTAL
Intervention: Communication intervention
Number of subjects: 537

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study: 32991991

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 12.5 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 10.0-20.0 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 10.0-12.5 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 12.5-15.0 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 10.0 and 12.5 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 7.5-17.5 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) at 10-12.5 g kg‐1 diet
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Dietary isoleucine (Ile) requirement
Number of subjects: 630
Study: 32130593

Group type: EXPERIMENTAL
Intervention: 12-week jogging intervention
Number of subjects: 27
Study: 35184255

Group type: EXPERIMENTAL
Intervention: Cefiderocol 2g, q8h, for 7–14 days
Number of subjects: 84

Group type: COMPARATOR
Intervention: Comparators (imipenem/cilastatin, meropenem, best available therapy)
Number of subjects: 84
Study: 32126528

Group type: EXPERIMENTAL
Intervention: Alpha down-regulation neurofeedback training (NFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham-control group (random beta NFT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha down-regulation NFT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All participants
Number of subjects: 0
Study: 36029952

Group type: EXPERIMENTAL
Intervention: Telehealth Care intervention
Number of subjects: 1945

Group type: COMPARATOR
Intervention: Clinic-based Care intervention
Number of subjects: 1945
Study: 34242627

Group type: EXPERIMENTAL
Intervention: Combined treatment (behavioral and pelvic floor muscle therapies with midurethral sling surgery)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Midurethral sling surgery alone
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Combined treatment (for women with Urogenital Distress Inventory irritative scores of ≥50th percentile)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Midurethral sling surgery alone (for women with Urogenital Distress Inventory irritative scores of ≥50th percentile)
Number of subjects: 480